With this new contract, over 35 per cent of Jubilant Ingrevia’s overall energy needs across all manufacturing facilities will be fulfilled through renewable sources Read More | Source: The Hindu Business Line…
View More Jubilant Ingrevia signs RE deal with O2 PowerCategory: Markets
MF equity inflows tapper as markets tank
Investors are adopting a cautious yet steady approach, reassessing their portfolios while maintaining long-term investment commitments, say experts Read More | Source: The Hindu Business Line…
View More MF equity inflows tapper as markets tankTop gainers & losers today, 12 Mar: IndusInd Bank, Tata Motors gain; Infosys, Tech Mahindra slip
The Sensex closed at 74,029.76, down by 72.56 points or 0.10 per cent, while the Nifty 50 slipped 27.40 points or 0.12 per cent to end at 22,470.50 Read More | Source: The Hindu Business Line…
View More Top gainers & losers today, 12 Mar: IndusInd Bank, Tata Motors gain; Infosys, Tech Mahindra slipEquity market may be nearing end of correction phase: Motilal Oswal
Motilal prefers Reliance Industries, Bharti Airtel, Hindustan Unilever, L&T, Maruti, Titan, Adani Ports, Bharat Electronics, LTIMindtree, Shriram Finance, JSW Energy and Polycab among large-caps Read More | Source: The Hindu Business Line…
View More Equity market may be nearing end of correction phase: Motilal OswalSensex, Nifty close marginally lower as IT stocks drag; IndusInd Bank rebounds 4.38%
The Sensex closed at 74,029.76, down by 72.56 points or 0.10 per cent, while the Nifty 50 slipped 27.40 points or 0.12 per cent to end at 22,470.50 Read More | Source: The Hindu Business Line…
View More Sensex, Nifty close marginally lower as IT stocks drag; IndusInd Bank rebounds 4.38%Zydus gains FDA approval for urinary tract infection medication
The approval strengthens Zydus’ position in the US pharmaceutical market, bringing the company’s total to 419 USFDA approvals Read More | Source: The Hindu Business Line…
View More Zydus gains FDA approval for urinary tract infection medicationEaseMyTrip partners with Sukoon Unlimited to offer specialised services for senior travellers
Exclusive benefits for senior citizens to include personalised booking assistance, special discounts, priority seating, and wheelchair services at airports Read More | Source: The Hindu Business Line…
View More EaseMyTrip partners with Sukoon Unlimited to offer specialised services for senior travellersNykaa forms new wholly owned subsidiary for beauty and personal care, shares trade down by 2.50%
The main objective of Nykaa Essentials Private Limited is to trade and deal in cosmetics, toiletries, beauty, personal care, healthcare products, lifestyle products, and perfumery goods Read More | Source: The Hindu Business Line…
View More Nykaa forms new wholly owned subsidiary for beauty and personal care, shares trade down by 2.50%Markets extend losses as tech stocks plummet; banking shows resilience
Infosys tumbles 5.7% in tech stock sell-off amid global trade concerns Read More | Source: The Hindu Business Line…
View More Markets extend losses as tech stocks plummet; banking shows resilienceTop gainers & losers intraday March 12, 2025: IndusInd lead gains, IT stocks Infosys, Wipro, Tech Mahindra drag
The broader index faced heavy volatility. Sensex depreciated 393.86 pts or 0.53% to 73,708.46 as at 1.02 pm, and Nifty 50 fell 132.55 pts or 0.59% to 22,365.35 Read More | Source: The Hindu Business Line…
View More Top gainers & losers intraday March 12, 2025: IndusInd lead gains, IT stocks Infosys, Wipro, Tech Mahindra dragTata Motors stock gains on remarks of JLR’s profitability targets, brokerages flag US tariffs concerns
Brokerages are cautiously optimistic on Tata Motors Read More | Source: The Hindu Business Line…
View More Tata Motors stock gains on remarks of JLR’s profitability targets, brokerages flag US tariffs concernsGlenmark expands diabetes portfolio with new Empagliflozin treatments
According to IQVIA data, the market for Empagliflozin and combinations in India was valued at 642 crore for the 12-month period ending January 2025 Read More | Source: The Hindu Business Line…
View More Glenmark expands diabetes portfolio with new Empagliflozin treatmentsAlkem launches low-cost diabetes drug in Indian market
The company is introducing several combination therapies including Empanorm L (empagliflozin and linagliptin), Empanorm Duo and Alsita E (empagliflozin and sitagliptin), and Empanorm M (empagliflozin and metformin) Read More | Source: The Hindu Business Line…
View More Alkem launches low-cost diabetes drug in Indian marketJTL Industries incorporates engineering subsidiary through partnership firm conversion
The newly formed subsidiary has already achieved commercial production in Phase-I of its expansion, producing 5,000 metric tons of HR coils monthly, with further expansion planned for upcoming quarters Read More | Source: The Hindu Business Line…
View More JTL Industries incorporates engineering subsidiary through partnership firm conversionWipro, Infosys, HCL Tech, TCS shares plunge amid US recession fears
Morgan Stanley downgrades Infosys to Equal Weight; ICRA forecasts muted IT sector growth Read More | Source: The Hindu Business Line…
View More Wipro, Infosys, HCL Tech, TCS shares plunge amid US recession fears